Back to search
Skin Toxicity in Patients on Checkpoint Inhibitors
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Skin Toxicity in Patients on Checkpoint Inhibitors trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Skin Toxicity in Patients on Checkpoint Inhibitors trials you may qualify forDue to recent approvals, a significant number of adult cancer patients are undergoing treatment with checkpoint inhibitor antibodies. While these treatments hav…
The aim of this therapeutic education program is to reduce the apparition of immune-related Adverse Event with patients treated with ICI